SAS Output

20-AUG-2018 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1609-Rare Tumor, Comb Nivo/Ipi 1 Y 1 Nivolumab + Ipilimumab 707 523 406 190 27 3 1 01/30/2017 356 164
            523 406 190 27 3 1      
 
Yes A071102-GBM, adj TMZ +/- Veliparib 0 E Total Registrations   134 24 17 0 0 0 02/02/2015 395 180
            134 24 17 0 0 0      
 
    1 E Total Registrations   49 12 10 7 3 3 02/02/2015    
            49 12 10 7 3 3      
 
  A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   35 4 0 0 0 0 02/22/2016 296 110
            35 4 0 0 0 0      
 
    1 E Total Registrations   5 0 0 0 0 0 02/22/2016    
            5 0 0 0 0 0      
 
  ARST1321-NonRhabdo STS,Pazopanib (PAZNTIS) 1 E Total Registrations   9 5 2 0 0 0 09/04/2015 263 120
            9 5 2 0 0 0      
 
  EAY131-MATCH 0 E Total Registrations   909 27 13 10 7 0 08/21/2015 478 241
            909 27 13 10 7 0      
 
    1 E Total Registrations   118 21 11 7 5 0 08/21/2015    
            118 21 11 7 5 0      
 
    2 E Total Registrations   8 2 0 0 0 0 08/21/2015    
            8 2 0 0 0 0      
 
    8 E Total Registrations   2 1 1 1 1 0 08/21/2015    
            2 1 1 1 1 0